111 related articles for article (PubMed ID: 9213524)
1. [An open and controlled study of effectiveness and tolerance of Livostin eyedrops].
Stara J; Krásný J; Plísková S; Síblová O
Cesk Slov Oftalmol; 1997 Feb; 53(1):46-8. PubMed ID: 9213524
[TBL] [Abstract][Full Text] [Related]
2. Onset of action, effectiveness and tolerance of levocabastine and nedocromil in topical therapy of seasonal allergic rhinoconjunctivitis. The Deutsche Rhinitis-Studiengruppe.
Kremer B; Tündermann A; Goldschmidt O
Arzneimittelforschung; 1998 Sep; 48(9):924-30. PubMed ID: 9793620
[TBL] [Abstract][Full Text] [Related]
3. [Antazoline/tetryzoline eyedrops in comparison with levocabastine eyedrops in acute allergic conjunctivitis].
Wertheimer R; Blessmann G
Klin Monbl Augenheilkd; 1997 Feb; 210(2):93-6. PubMed ID: 9229602
[TBL] [Abstract][Full Text] [Related]
4. [Multicenter evaluation of a new local antihistaminic drug (levocabastine)].
Bischoff P; Gerber M
Klin Monbl Augenheilkd; 1992 May; 200(5):354-7. PubMed ID: 1351957
[TBL] [Abstract][Full Text] [Related]
5. Ophthalmic levocabastine for allergic conjunctivitis.
Med Lett Drugs Ther; 1994 Apr; 36(920):35-6. PubMed ID: 7908401
[No Abstract] [Full Text] [Related]
6. [Allergodil eye drops in the treatment of allergic conjunctivitis].
Haicl P; Cerná H
Cesk Slov Oftalmol; 2002 Jul; 58(4):254-8. PubMed ID: 12181881
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis.
Verin P; Easty DL; Secchi A; Ciprandi G; Partouche P; Nemeth-Wasmer G; Brancato R; Harrisberg CJ; Estivin-Ebrardt C; Coster DJ; Apel AJ; Coroneo MT; Knorr M; Carmichael TR; Kent-Smith BT; Abrantes P; Leonardi A; Cerqueti PM; Modorati G; Martinez M
Am J Ophthalmol; 2001 Jun; 131(6):691-8. PubMed ID: 11384563
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
Borazan M; Karalezli A; Akova YA; Akman A; Kiyici H; Erbek SS
Acta Ophthalmol; 2009 Aug; 87(5):549-54. PubMed ID: 18631332
[TBL] [Abstract][Full Text] [Related]
9. [Alomide eyedrops in the treatment of allergic conjunctivitis and keratoconjunctivitis].
Maĭchuk IuF; Khaitova KN; Grishakova MB
Vestn Oftalmol; 1998; 114(4):43-4. PubMed ID: 9771090
[TBL] [Abstract][Full Text] [Related]
10. [Effects levocabastine ophthalmic solution (H1 receptor antagonist) on symptoms of vernal conjunctivitis. A prospective, randomized double-blind study].
Graue E
Gac Med Mex; 1994; 130(6):481-6. PubMed ID: 7557064
[TBL] [Abstract][Full Text] [Related]
11. Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis.
Giede C; Metzenauer P; Petzold U; Ellers-Lenz B
Curr Med Res Opin; 2000; 16(3):153-63. PubMed ID: 11191004
[TBL] [Abstract][Full Text] [Related]
12. [Effects of emedastine eyedrops on acute seasonal allergic conjunctivitis in children].
Endre L
Orv Hetil; 2003 Apr; 144(14):665-7. PubMed ID: 12795028
[TBL] [Abstract][Full Text] [Related]
13. [Levocabastine--a new antihistaminic for local treatment].
Larsen BB; Pedersen B; Dahl R
Ugeskr Laeger; 1993 Jun; 155(26):2070-3. PubMed ID: 8101023
[No Abstract] [Full Text] [Related]
14. Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.
Abelson MB; Greiner JV
Curr Med Res Opin; 2004 Dec; 20(12):1953-8. PubMed ID: 15701212
[TBL] [Abstract][Full Text] [Related]
15. The effect of a combined therapy with a histamine H1 antagonist and a chemical mediator release inhibitor on allergic conjunctivitis.
Fujishima H; Fukagawa K; Tanaka M; Uchio E; Takamura E; Nakagawa Y; Miyazaki D; Fukushima A; Okamoto S; Yokoi N
Ophthalmologica; 2008; 222(4):232-9. PubMed ID: 18463425
[TBL] [Abstract][Full Text] [Related]
16. Olopatadine for allergic conjunctivitis.
Med Lett Drugs Ther; 1997 Nov; 39(1014):108-9. PubMed ID: 9398823
[No Abstract] [Full Text] [Related]
17. Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis.
Abelson MB; Gomes PJ; Vogelson CT; Pasquine TA; Turner FD; Wells DT; Robertson SM
Curr Med Res Opin; 2005 May; 21(5):683-91. PubMed ID: 15969867
[TBL] [Abstract][Full Text] [Related]
18. Emedastine and allergic conjunctivitis: new preparation. Poor assessment.
Prescrire Int; 2001 Apr; 10(52):39-40. PubMed ID: 11718155
[TBL] [Abstract][Full Text] [Related]
19. [The curative effect of livostin spray on treating allergic rhinitis of children].
Wang S; Xu Z; Xu R; Wang Z; Rao K
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Apr; 15(4):171-2. PubMed ID: 12541644
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and artificial tears in seasonal allergic conjunctivitis.
Kamis U; Ozturk BT; Ozkagnici A; Gunduz K
Acta Ophthalmol Scand; 2006 Feb; 84(1):148-9. PubMed ID: 16445458
[No Abstract] [Full Text] [Related]
[Next] [New Search]
